Sickle cell priapism;Priapismo na doença falciforme

Revista Brasileira de Hematologia e Hemoterapia

Volumn 29, Issue 3, 2007, Pages 275-278

  Vicari, Perla ^a   Figueiredo, Maria Stella ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adrenergic agonists; Diethylstilbestrol; Priapism; Sickle cell disease

Indexed keywords

EID: 38049117901     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Keoghane SR, Sullivan ME, Miller MAW. The aetiology, pathogenesis and management of priapism. BJU International. 2002;90:149-54.
2. Pryor J, Akkus E, Alter G, et al. Priapism. J Sex Med. 2004;1(1):116-20.
3. Diggs LW, Ching RE. Pathology of sickle cell anaemia. South Med J. 1934;27:839-45.
4. Adeyoju AB, Olujohungbe ABK, Morris J et al. Priapism in sickle-cell disease: incidence, risk factors and complications - an international multicentre study. BJU International 2002;90:898-902.
5. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007;21:37-47.
6. Daley JT, Brown ML, Watkins MT et al. Prostanoid production in rabbit corpus cavernosum: Regulation by oxygen tension. J Urol. 1996;155:1482-7.
7. Lottenberg R, Hassell KL. An evidence-based approach to the treatment of adults with sickle cell disease. Education program book, Hematology. 2005:58-65.
8. Molina L, Bejany D, Lynne CM et al. Diluted epinephrine solutions for the treatment of priapism. J Urol. 1989;141:1127-8.
9. Mandatakis E, Ewalt DH, Cavender JD, Rogers ZR, Buchanan GR. Out-patient penile aspiration and epinephrine irrigation for young patients with sickle cell anaemia and prolonged priapism. Blood. 2000;95:78-82.
10. Lowe FC, Jarrow JP. Placebo controlled study of oral terbutaline and pseudoephedrine in the manegement of prostaglandin induced prolonged erections. Urology. 1993;42:51-3.
11. Gbadoe AD, Atakouma Y, Kusiaku K et al. Management of sickle cell priapism with etilefrine. Arch Dis Child. 2001;85:52-3.
12. Virag R, Bachir D, Lee K et al. Preventive treatment of priapism in sickle cell disease with oral and self-administered intracavernous injection of etilefrine. Urology. 1996;47:777-81.
13. Levine LA, Guss SP. Gonadotropin-releasing hormone analogues in the treatment of sickle cell anemia-associated priapism. J Urol. 1993;150:475-7.
14. Steinberg J, Eyre RC. Management of recurrent priapism with epinephrine self-injection and gonadotropin-releasing hormone analogue. J Urol. 1995;153:152-3.
15. Serjeant GR, de Ceulaer K, Maude GH. Stilboestrol and stuttering priapism in homozygous sickle-cell disease. Lancet. 1985;2:1274-6.
16. Al Jam'a AH, Al Dabbous IA. Hydroxyurea in the treatment of sickle cell associated priapism. J Urol. 1998;159:1642.
17. Maples B, hagemann TM. Treatment of priapism in pediatric patients with sickle cell disease. Am J Health-Syst Pharm. 2004;61:355-63.
18. Merritt AL, Haiman C, Henderson SO. Myth: blood transfusion is effective for sickle cell anemia-associated priaprism. CJEM. 2006; 8:119-22.
19. Hamre MR, Harmon EP, Kirkpatrick DV, Satern MJ, Humbert JR. Priapism as a complication of sickle cell disease. J Urol. 1991;145:1-5.